TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs7970350
log Bayes Factor = 1.08872
Chromosome 12   position 66,360,164  (GRCh37) Explore rs7970350 on Ensembl!
Variant rs7970350 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E11.9 Without complications
0.904 0.096 0.000
E11 Non-insulin-dependent diabetes mellitus
0.650 0.350 0.000
E11.3 With ophthalmic complications
0.615 0.385 0.000
E11.6 With other specified complications
0.555 0.445 0.000
E11.8 With unspecified complications
0.542 0.458 0.000
E11.1 With ketoacidosis
0.523 0.477 0.000
E11.0 With coma
0.468 0.532 0.000
E11.7 With multiple complications
0.466 0.534 0.000
E11.2 With renal complications
0.406 0.594 0.000
E11.5 With peripheral circulatory complications
0.245 0.755 0.000
I89.0 Lymphoedema, not elsewhere classified
0.208 0.792 0.000
E11.4 With neurological complications
0.166 0.834 0.000
I89 Other non-infective disorders of lymphatic vessels and lymph nodes
0.161 0.839 0.000
I89.8 Other specified non-infective disorders of lymphatic vessels and lymph nodes
0.144 0.856 0.000
I89.1 Lymphangitis
0.132 0.868 0.000
I89.9 Non-infective disorder of lymphatic vessels and lymph nodes, unspecified
0.119 0.881 0.000
C43.7 Malignant melanoma of lower limb, including hip
0.000 0.928 0.072
C43 Malignant melanoma of skin
0.000 0.929 0.071
C43.9 Malignant melanoma of skin, unspecified
0.000 0.931 0.069
C43.5 Malignant melanoma of trunk
0.000 0.932 0.068
E10-E14 Diabetes mellitus
0.067 0.933 0.000
C43.4 Malignant melanoma of scalp and neck
0.000 0.934 0.066
C43.6 Malignant melanoma of upper limb, including shoulder
0.000 0.942 0.058
C43.8 Overlapping malignant melanoma of skin
0.000 0.949 0.051
C43.0 Malignant melanoma of lip
0.000 0.949 0.051
E12 Malnutrition-related diabetes mellitus
0.048 0.952 0.000
C43.2 Malignant melanoma of ear and external auricular canal
0.000 0.956 0.043
C43.1 Malignant melanoma of eyelid, including canthus
0.000 0.960 0.039
E13 Other specified diabetes mellitus
0.035 0.965 0.000
E12.9 Without complications
0.035 0.965 0.000
E12.8 With unspecified complications
0.035 0.965 0.000
E12.7 With multiple complications
0.035 0.965 0.000
E12.6 With other specified complications
0.035 0.965 0.000
E12.5 With peripheral circulatory complications
0.035 0.965 0.000
E12.4 With neurological complications
0.035 0.965 0.000
E12.3 With ophthalmic complications
0.035 0.965 0.000
E12.2 With renal complications
0.035 0.965 0.000
E12.1 With ketoacidosis
0.035 0.965 0.000
E12.0 With coma
0.035 0.965 0.000
E14 Unspecified diabetes mellitus
0.033 0.967 0.000
E14.2 Withrenal complications
0.029 0.971 0.000
C43.3 Malignant melanoma of other and unspecified parts of face
0.000 0.972 0.028
E04.2 Non-toxic multinodular goitre
0.026 0.974 0.000
E14.1 With ketoacidosis
0.026 0.974 0.000
E13.8 With unspecified complications
0.025 0.974 0.000
E13.7 With multiple complications
0.025 0.974 0.000
E13.6 With other specified complications
0.025 0.974 0.000
E13.5 With peripheral circulatory complications
0.025 0.974 0.000
E13.4 With neurological complications
0.025 0.974 0.000
E13.2 With renal complications
0.025 0.974 0.000
E13.1 With ketoacidosis
0.025 0.974 0.000
E13.0 With coma
0.025 0.974 0.000
E13.3 With ophthalmic complications
0.024 0.976 0.000
E14.8 With unspecified complications
0.024 0.976 0.000
E14.7 With multiple complications
0.024 0.976 0.000
E14.0 With coma
0.024 0.976 0.000
E14.4 With neurological complications
0.023 0.977 0.000
I62.0 Subdural haemorrhage (acute) (nontraumatic)
0.000 0.977 0.023
E10 Insulin-dependent diabetes mellitus
0.022 0.978 0.000
D75.2 Essential thrombocytosis
0.022 0.978 0.000
E14.6 With other specified complications
0.021 0.978 0.000
E14.9 Without complications
0.021 0.979 0.000
N36.8 Other specified disorders of urethra
0.000 0.980 0.020
E10.1 With ketoacidosis
0.019 0.981 0.000
E10.0 With coma
0.018 0.982 0.000
N36.2 Urethral caruncle
0.000 0.982 0.018
E10.6 With other specified complications
0.017 0.983 0.000
N36 Other disorders of urethra
0.000 0.983 0.017
I62 Other nontraumatic intracranial haemorrhage
0.000 0.984 0.016
E10.7 With multiple complications
0.016 0.984 0.000
I62.9 Intracranial haemorrhage (nontraumatic), unspecified
0.000 0.984 0.016
E10.8 With unspecified complications
0.015 0.985 0.000
E13.9 Without complications
0.015 0.985 0.000
E14.5 With peripheral circulatory complications
0.014 0.985 0.001
E10.2 With renal complications
0.014 0.986 0.000
E10.3 With ophthalmic complications
0.014 0.986 0.000
N36.1 Urethral diverticulum
0.000 0.986 0.013
K80.4 Calculus of bile duct with cholecystitis
0.013 0.987 0.000
E14.3 With ophthalmic complications
0.013 0.987 0.000
C43-C44 Melanoma and other malignant neoplasms of skin
0.000 0.988 0.012
N36.3 Prolapsed urethral mucosa
0.000 0.988 0.012
I62.1 Nontraumatic extradural haemorrhage
0.000 0.988 0.012
N36.9 Urethral disorder, unspecified
0.000 0.989 0.011
W18.3 Sports and athletics area
0.011 0.989 0.000
E10.5 With peripheral circulatory complications
0.011 0.989 0.000
E04 Other non-toxic goitre
0.010 0.990 0.000
D47.3 Essential (haemorrhagic) thrombocythaemia
0.010 0.990 0.000
D47.2 Monoclonal gammopathy
0.009 0.991 0.000
N36.0 Urethral fistula
0.000 0.991 0.009
I77.8 Other specified disorders of arteries and arterioles
0.009 0.991 0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.009 0.991 0.000
W18 Other fall on same level
0.008 0.992 0.000
E10.9 Without complications
0.008 0.992 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.008 0.992 0.000
E10.4 With neurological complications
0.008 0.992 0.000
W18.1 Residential institution
0.008 0.992 0.000
E04.0 Non-toxic diffuse goitre
0.008 0.992 0.000
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.008 0.992 0.000
D86.9 Sarcoidosis, unspecified
0.008 0.992 0.000
E04.8 Other specified non-toxic goitre
0.007 0.992 0.000
E00-E07 Disorders of thyroid gland
0.008 0.992 0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
0.007 0.992 0.000
T51.9 Alcohol, unspecified
0.007 0.993 0.000
E50-E64 Other nutritional deficiencies
0.007 0.993 0.000
R16.0 Hepatomegaly, not elsewhere classified
0.007 0.993 0.000
E61.1 Iron deficiency
0.007 0.993 0.000
W18.5 Trade and service area
0.007 0.993 0.000
D47.4 Osteomyelofibrosis
0.007 0.993 0.000
E61 Deficiency of other nutrient elements
0.007 0.993 0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour
0.007 0.993 0.000
I83.1 Varicose veins of lower extremities with inflammation
0.000 0.993 0.007
I77.6 Arteritis, unspecified
0.007 0.993 0.000
I77 Other disorders of arteries and arterioles
0.007 0.993 0.000
D86 Sarcoidosis
0.007 0.993 0.000
E40-E46 Malnutrition
0.007 0.993 0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]
0.006 0.993 0.000
E58 Dietary calcium deficiency
0.006 0.994 0.000
E04.9 Non-toxic goitre, unspecified
0.006 0.994 0.000
W18.9 Unspecified place
0.006 0.994 0.000
W18.8 Other specified place
0.006 0.994 0.000
W18.4 Street and highway
0.006 0.994 0.000
W18.2 School, other institution and public administrative area
0.006 0.994 0.000
W18.0 Home
0.006 0.994 0.000
W18.7 Farm
0.006 0.994 0.000
W18.6 Industrial and construction area
0.006 0.994 0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.000 0.994 0.006
E05 Thyrotoxicosis [hyperthyroidism]
0.006 0.994 0.000
D80-D89 Certain disorders involving the immune mechanism
0.006 0.994 0.000
I77.3 Arterial fibromuscular dysplasia
0.006 0.994 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.006 0.994 0.000
E51 Thiamine deficiency
0.006 0.994 0.000
E54 Ascorbic acid deficiency
0.006 0.994 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.006 0.994 0.000
I77.0 Arteriovenous fistula, acquired
0.006 0.994 0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.006 0.994 0.000
E00 Congenital iodine-deficiency syndrome
0.006 0.994 0.000
D86.0 Sarcoidosis of lung
0.006 0.994 0.000
E64 Sequelae of malnutrition and other nutritional deficiencies
0.005 0.994 0.000
E63 Other nutritional deficiencies
0.005 0.994 0.000
E50 Vitamin A deficiency
0.005 0.994 0.000
E60 Dietary zinc deficiency
0.005 0.994 0.000
E59 Dietary selenium deficiency
0.005 0.994 0.000
E52 Niacin deficiency [pellagra]
0.005 0.994 0.000
E02 Subclinical iodine-deficiency hypothyroidism
0.005 0.994 0.000
E56 Other vitamin deficiencies
0.005 0.994 0.000
E46 Unspecified protein-energy malnutrition
0.005 0.995 0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.005 0.995 0.000
E61.9 Deficiency of nutrient element, unspecified
0.005 0.995 0.000
E61.8 Deficiency of other specified nutrient elements
0.005 0.995 0.000
E61.7 Deficiency of multiple nutrient elements
0.005 0.995 0.000
E61.6 Vanadium deficiency
0.005 0.995 0.000
E61.5 Molybdenum deficiency
0.005 0.995 0.000
E61.4 Chromium deficiency
0.005 0.995 0.000
E61.3 Manganese deficiency
0.005 0.995 0.000
E61.0 Copper deficiency
0.005 0.995 0.000
J38.0 Paralysis of vocal cords and larynx
0.000 0.995 0.005
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes
0.005 0.995 0.000
D84 Other immunodeficiencies
0.005 0.995 0.000
D80 Immunodeficiency with predominantly antibody defects
0.005 0.995 0.000
E05.9 Thyrotoxicosis, unspecified
0.005 0.995 0.000
E61.2 Magnesium deficiency
0.005 0.995 0.000
T46.1 Calcium-channel blockers
0.005 0.995 0.000
I77.5 Necrosis of artery
0.005 0.995 0.000
I77.4 Coeliac artery compression syndrome
0.005 0.995 0.000
I77.2 Rupture of artery
0.005 0.995 0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified
0.005 0.995 0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)
0.000 0.995 0.005
D86.8 Sarcoidosis of other and combined sites
0.005 0.995 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.005 0.995 0.000
E44 Protein-energy malnutrition of moderate and mild degree
0.005 0.995 0.000
E45 Retarded development following protein-energy malnutrition
0.005 0.995 0.000
E43 Unspecified severe protein-energy malnutrition
0.005 0.995 0.000
E42 Marasmic kwashiorkor
0.005 0.995 0.000
E41 Nutritional marasmus
0.005 0.995 0.000
E40 Kwashiorkor
0.005 0.995 0.000
E53 Deficiency of other B group vitamins
0.005 0.995 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.005 0.995 0.000
K22.8 Other specified diseases of oesophagus
0.005 0.995 0.000
K27.9 Unspecified as acute or chronic, without haemorrhage or perforation
0.005 0.995 0.000
D84.9 Immunodeficiency, unspecified
0.005 0.995 0.000
D89.9 Disorder involving the immune mechanism, unspecified
0.005 0.995 0.000
E06 Thyroiditis
0.005 0.995 0.000
K80.0 Calculus of gallbladder with acute cholecystitis
0.005 0.995 0.000
D83 Common variable immunodeficiency
0.005 0.995 0.000
W18.09 Other fall on same level: Home: During unspecified activity
0.005 0.995 0.000
W18.04 Other fall on same level, Home , While resting, sleeping, eating or engaging in other vital activities
0.005 0.995 0.000
W18.22 Other fall on same level; School, other institution and public administrative area; While working for income
0.005 0.995 0.000
W18.49 Other fall on same level; Street and highway; During unspecified activity
0.005 0.995 0.000
W18.48 Other fall on same level; Street and highway; While engaged in other specified activities
0.005 0.995 0.000
W18.89 Other fall on same level; Other specified places; During unspecified activity
0.005 0.995 0.000
W18.99 Other fall on same level; Unspecified place; During unspecified activity
0.005 0.995 0.000
W18.93 Other fall on same level; Unspecified place; While engaged in other types of work
0.005 0.995 0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.995 0.005
J61 Pneumoconiosis due to asbestos and other mineral fibres
0.005 0.995 0.000
I47.2 Ventricular tachycardia
0.000 0.995 0.005
I77.9 Disorder of arteries and arterioles, unspecified
0.005 0.995 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.005 0.995 0.000
D82 Immunodeficiency associated with other major defects
0.005 0.995 0.000
E51.2 Wernicke's encephalopathy
0.005 0.995 0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified
0.005 0.995 0.000
O75.7 Vaginal delivery following previous Caesarean section
0.005 0.995 0.000
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses
0.005 0.995 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.005 0.995 0.000
M31.6 Other giant cell arteritis
0.005 0.995 0.000
D86.1 Sarcoidosis of lymph nodes
0.004 0.995 0.000
D86.3 Sarcoidosis of skin
0.004 0.995 0.000
E05.5 Thyroid crisis or storm
0.004 0.995 0.000
E05.4 Thyrotoxicosis factitia
0.004 0.995 0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.004 0.995 0.000
H59.8 Other postprocedural disorders of eye and adnexa
0.000 0.995 0.005
D81 Combined immunodeficiencies
0.004 0.995 0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.004 0.995 0.000
M06.9 Rheumatoid arthritis, unspecified
0.000 0.995 0.004
M31.3 Wegener's granulomatosis
0.004 0.996 0.000
E51.9 Thiamine deficiency, unspecified
0.004 0.996 0.000
E51.8 Other manifestations of thiamine deficiency
0.004 0.996 0.000
E51.1 Beriberi
0.004 0.996 0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.000 0.996 0.004
M06.0 Seronegative rheumatoid arthritis
0.000 0.996 0.004
O75.8 Other specified complications of labour and delivery
0.004 0.996 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.004 0.996 0.000
T46.7 Peripheral vasodilators
0.004 0.996 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.004 0.996 0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
0.004 0.996 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.004 0.996 0.000
E05.8 Other thyrotoxicosis
0.004 0.996 0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.004 0.996 0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.004 0.996 0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.004 0.996 0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.004 0.996 0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.004 0.996 0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.004 0.996 0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.004 0.996 0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.004 0.996 0.000
D80.1 Nonfamilial hypogammaglobulinaemia
0.004 0.996 0.000
D84.8 Other specified immunodeficiencies
0.004 0.996 0.000
E50.9 Vitamin A deficiency, unspecified
0.004 0.996 0.000
E50.8 Other manifestations of vitamin A deficiency
0.004 0.996 0.000
E50.7 Other ocular manifestations of vitamin A deficiency
0.004 0.996 0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.004 0.996 0.000
E50.5 Vitamin A deficiency with night blindness
0.004 0.996 0.000
E50.4 Vitamin A deficiency with keratomalacia
0.004 0.996 0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.004 0.996 0.000
E50.2 Vitamin A deficiency with corneal xerosis
0.004 0.996 0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.004 0.996 0.000
E50.0 Vitamin A deficiency with conjunctival xerosis
0.004 0.996 0.000
E63.9 Nutritional deficiency, unspecified
0.004 0.996 0.000
E63.8 Other specified nutritional deficiencies
0.004 0.996 0.000
E63.1 Imbalance of constituents of food intake
0.004 0.996 0.000
E63.0 Essential fatty acid [EFA] deficiency
0.004 0.996 0.000
E64.9 Sequelae of unspecified nutritional deficiency
0.004 0.996 0.000
E64.8 Sequelae of other nutritional deficiencies
0.004 0.996 0.000
E64.3 Sequelae of rickets
0.004 0.996 0.000
E64.2 Sequelae of vitamin C deficiency
0.004 0.996 0.000
E64.1 Sequelae of vitamin A deficiency
0.004 0.996 0.000
E64.0 Sequelae of protein-energy malnutrition
0.004 0.996 0.000
E56.9 Vitamin deficiency, unspecified
0.004 0.996 0.000
E56.8 Deficiency of other vitamins
0.004 0.996 0.000
E56.0 Deficiency of vitamin E
0.004 0.996 0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified
0.004 0.996 0.000
D75 Other diseases of blood and blood-forming organs
0.004 0.996 0.000
O75 Other complications of labour and delivery, not elsewhere classified
0.004 0.996 0.000
E56.1 Deficiency of vitamin K
0.004 0.996 0.000
D80.8 Other immunodeficiencies with predominantly antibody defects
0.004 0.996 0.000
D80.7 Transient hypogammaglobulinaemia of infancy
0.004 0.996 0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]
0.004 0.996 0.000
D80.0 Hereditary hypogammaglobulinaemia
0.004 0.996 0.000
D84.0 Lymphocyte function antigen-1 [LFA-1] defect
0.004 0.996 0.000
M31 Other necrotising vasculopathies
0.004 0.996 0.000
I35.0 Aortic (valve) stenosis
0.004 0.996 0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]
0.004 0.996 0.000
D83.9 Common variable immunodeficiency, unspecified
0.004 0.996 0.000
D84.1 Defects in the complement system
0.004 0.996 0.000
E07 Other disorders of thyroid
0.004 0.996 0.000
K80 Cholelithiasis
0.004 0.996 0.000
D47.1 Chronic myeloproliferative disease
0.004 0.996 0.000
M06.09 Seronegative rheumatoid arthritis (Site unspecified)
0.000 0.996 0.004
D89.3 Immune reconstitution syndrome
0.004 0.996 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.004 0.996 0.000
M06 Other rheumatoid arthritis
0.000 0.996 0.004
E44.1 Mild protein-energy malnutrition
0.004 0.996 0.000
E44.0 Moderate protein-energy malnutrition
0.004 0.996 0.000
E53.1 Pyridoxine deficiency
0.004 0.996 0.000
E53.0 Riboflavin deficiency
0.004 0.996 0.000
E53.9 Vitamin B deficiency, unspecified
0.004 0.996 0.000
E06.1 Subacute thyroiditis
0.004 0.996 0.000
D89.1 Cryoglobulinaemia
0.004 0.996 0.000
D89.0 Polyclonal hypergammaglobulinaemia
0.004 0.996 0.000
E06.5 Other chronic thyroiditis
0.004 0.996 0.000
D82.1 Di George's syndrome
0.004 0.996 0.000
O75.6 Delayed delivery after spontaneous or unspecified rupture of membranes
0.004 0.996 0.000
M06.34 Rheumatoid nodule (Hand)
0.000 0.996 0.004
D75.9 Disease of blood and blood-forming organs, unspecified
0.004 0.996 0.000
D83.8 Other common variable immunodeficiencies
0.004 0.996 0.000
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells
0.004 0.996 0.000
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
0.004 0.996 0.000
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
0.004 0.996 0.000
E06.4 Drug-induced thyroiditis
0.004 0.996 0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.004 0.996 0.000
E06.0 Acute thyroiditis
0.004 0.996 0.000
E55 Vitamin D deficiency
0.004 0.996 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.004 0.996 0.000
I49.3 Ventricular premature depolarisation
0.000 0.996 0.004
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.004 0.996 0.000
D82.9 Immunodeficiency associated with major defect, unspecified
0.003 0.996 0.000
D82.8 Immunodeficiency associated with other specified major defects
0.003 0.996 0.000
D82.4 Hyperimmunoglobulin E [IgE] syndrome
0.003 0.996 0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus
0.003 0.996 0.000
D82.2 Immunodeficiency with short-limbed stature
0.003 0.996 0.000
D82.0 Wiskott-Aldrich syndrome
0.003 0.996 0.000
M31.7 Microscopic polyangiitis
0.004 0.996 0.000
M06.06 Seronegative rheumatoid arthritis (Lower leg)
0.000 0.996 0.004
O75.0 Maternal distress during labour and delivery
0.004 0.996 0.000
O75.5 Delayed delivery after artificial rupture of membranes
0.004 0.996 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.004 0.996 0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.996 0.004
I77.1 Stricture of artery
0.004 0.996 0.000
M06.3 Rheumatoid nodule
0.000 0.996 0.003
T36-T50 Poisoning by drugs, medicaments and biological substances
0.004 0.996 0.000
D81.9 Combined immunodeficiency, unspecified
0.003 0.996 0.000
D81.8 Other combined immunodeficiencies
0.003 0.996 0.000
D81.7 Major histocompatibility complex class II deficiency
0.003 0.996 0.000
D81.6 Major histocompatibility complex class I deficiency
0.003 0.996 0.000
D81.5 Purine nucleoside phosphorylase [PNP] deficiency
0.003 0.996 0.000
D81.4 Nezelof's syndrome
0.003 0.996 0.000
D81.3 Adenosine deaminase [ADA] deficiency
0.003 0.996 0.000
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers
0.003 0.996 0.000
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
0.003 0.996 0.000
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis
0.003 0.996 0.000
M79.69 Pain in limb (Site unspecified)
0.000 0.996 0.004
E06.9 Thyroiditis, unspecified
0.003 0.996 0.000
N17.9 Acute renal failure, unspecified
0.004 0.996 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.004 0.996 0.000
E20-E35 Disorders of other endocrine glands
0.004 0.996 0.000
K80.8 Other cholelithiasis
0.003 0.997 0.000
M06.08 Seronegative rheumatoid arthritis (Other)
0.000 0.997 0.003
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)
0.000 0.997 0.003
M06.03 Seronegative rheumatoid arthritis (Forearm)
0.000 0.997 0.003
M06.02 Seronegative rheumatoid arthritis (Upper arm)
0.000 0.997 0.003
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.000 0.997 0.003
E15 Nondiabetic hypoglycaemic coma
0.003 0.997 0.000
M31.8 Other specified necrotising vasculopathies
0.003 0.997 0.000
M06.4 Inflammatory polyarthropathy
0.000 0.997 0.003
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.003 0.997 0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]
0.003 0.997 0.000
L03.2 Cellulitis of face
0.003 0.997 0.000
M31.4 Aortic arch syndrome [Takayasu]
0.003 0.997 0.000
M31.5 Giant cell arteritis with polymyalgia rheumatica
0.003 0.997 0.000
D89.2 Hypergammaglobulinaemia, unspecified
0.003 0.997 0.000
E53.8 Deficiency of other specified B group vitamins
0.003 0.997 0.000
O41.0 Oligohydramnios
0.003 0.997 0.000
O75.9 Complication of labour and delivery, unspecified
0.003 0.997 0.000
O75.4 Other complications of obstetric surgery and procedures
0.003 0.997 0.000
O75.3 Other infection during labour
0.003 0.997 0.000
O75.1 Shock during or following labour and delivery
0.003 0.997 0.000
M06.04 Seronegative rheumatoid arthritis (Hand)
0.000 0.997 0.003
T47.6 Antidiarrhoeal drugs
0.003 0.997 0.000
M06.30 Rheumatoid nodule (Multiple sites)
0.000 0.997 0.003
E20 Hypoparathyroidism
0.003 0.997 0.000
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)
0.000 0.997 0.003
M31.2 Lethal midline granuloma
0.003 0.997 0.000
T38.0 Glucocorticoids and synthetic analogues
0.003 0.997 0.000
S61.9 Open wound of wrist and hand, part unspecified
0.000 0.997 0.003
E07.1 Dyshormogenetic goitre
0.003 0.997 0.000
E07.0 Hypersecretion of calcitonin
0.003 0.997 0.000
K80.3 Calculus of bile duct with cholangitis
0.003 0.997 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.003 0.997 0.000
E65-E68 Obesity and other hyperalimentation
0.003 0.997 0.000
T47.2 Stimulant laxatives
0.003 0.997 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.003 0.997 0.000
M06.49 Inflammatory polyarthropathy (Site unspecified)
0.000 0.997 0.003
M31.9 Necrotising vasculopathy, unspecified
0.003 0.997 0.000
M31.1 Thrombotic microangiopathy
0.003 0.997 0.000
T38.5 Other oestrogens and progestogens
0.003 0.997 0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.003 0.997 0.000
M06.2 Rheumatoid bursitis
0.000 0.997 0.003
M06.1 Adult-onset Still's disease
0.000 0.997 0.003
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.997 0.003
E34 Other endocrine disorders
0.003 0.997 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.003 0.997 0.000
D75.0 Familial erythrocytosis
0.003 0.997 0.000
E20.9 Hypoparathyroidism, unspecified
0.003 0.997 0.000
T38.1 Thyroid hormones and substitutes
0.003 0.997 0.000
T50.8 Diagnostic agents
0.003 0.997 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.003 0.997 0.000
E34.8 Other specified endocrine disorders
0.003 0.997 0.000
M31.0 Hypersensitivity angiitis
0.003 0.997 0.000
T47.4 Other laxatives
0.003 0.997 0.000
M06.01 Seronegative rheumatoid arthritis (Shoulder region)
0.000 0.997 0.003
T38.8 Other and unspecified hormones and their synthetic substitutes
0.003 0.997 0.000
E55.0 Rickets, active
0.003 0.997 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.003 0.997 0.000
K80.5 Calculus of bile duct without cholangitis or cholecystitis
0.003 0.997 0.000
O66.5 Failed application of vacuum extractor and forceps, unspecified
0.003 0.997 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.003 0.997 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.003 0.997 0.000
T47.7 Emetics
0.003 0.997 0.000
T47.5 Digestants
0.003 0.997 0.000
T47.3 Saline and osmotic laxatives
0.003 0.997 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.003 0.997 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.003 0.997 0.000
E07.8 Other specified disorders of thyroid
0.003 0.997 0.000
E29 Testicular dysfunction
0.003 0.997 0.000
R01.1 Cardiac murmur, unspecified
0.003 0.997 0.000
T38.9 Other and unspecified hormone antagonists
0.003 0.997 0.000
T38.7 Androgens and anabolic congeners
0.003 0.997 0.000
T38.4 Oral contraceptives
0.003 0.997 0.000
T38.2 Antithyroid drugs
0.003 0.997 0.000
T17.2 Foreign body in pharynx
0.003 0.997 0.000
T47.0 Histamine H(2)-receptor antagonists
0.003 0.997 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.003 0.997 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.003 0.997 0.000
T45.0 Antiallergic and antiemetic drugs
0.003 0.997 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.003 0.997 0.000
M06.39 Rheumatoid nodule (Site unspecified)
0.000 0.997 0.003
M06.38 Rheumatoid nodule (Other)
0.000 0.997 0.003
M06.36 Rheumatoid nodule (Lower leg)
0.000 0.997 0.003
M06.35 Rheumatoid nodule (Pelvic region and thigh)
0.000 0.997 0.003
M06.31 Rheumatoid nodule (Shoulder region)
0.000 0.997 0.003
T50.7 Analeptics and opioid receptor antagonists
0.003 0.997 0.000
T50.5 Appetite depressants
0.003 0.997 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.003 0.997 0.000
T50.1 Loop [high-ceiling] diuretics
0.003 0.997 0.000
T50.0 Mineralocorticoids and their antagonists
0.003 0.997 0.000
E35 Disorders of endocrine glands in diseases classified elsewhere
0.003 0.997 0.000
E32 Diseases of thymus
0.003 0.997 0.000
E30 Disorders of puberty, not elsewhere classified
0.003 0.997 0.000
R16 Hepatomegaly and splenomegaly, not elsewhere classified
0.003 0.997 0.000
E22 Hyperfunction of pituitary gland
0.003 0.997 0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.997 0.003
T37.8 Other specified systemic anti-infectives and antiparasitics
0.003 0.997 0.000
E25 Adrenogenital disorders
0.003 0.997 0.000
E06.3 Autoimmune thyroiditis
0.003 0.997 0.000
A87.9 Viral meningitis, unspecified
0.000 0.997 0.003
E31 Polyglandular dysfunction
0.003 0.997 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.003 0.997 0.000
E34.3 Short stature, not elsewhere classified
0.003 0.997 0.000
R82.4 Acetonuria
0.003 0.997 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.003 0.997 0.000
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified
0.000 0.997 0.003
M06.48 Inflammatory polyarthropathy (Other)
0.000 0.997 0.003
M06.47 Inflammatory polyarthropathy (Ankle and foot)
0.000 0.997 0.003
M06.46 Inflammatory polyarthropathy (Lower leg)
0.000 0.997 0.003
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)
0.000 0.997 0.003
M06.44 Inflammatory polyarthropathy (Hand)
0.000 0.997 0.003
M06.43 Inflammatory polyarthropathy (Forearm)
0.000 0.997 0.003
M06.42 Inflammatory polyarthropathy (Upper arm)
0.000 0.997 0.003
M06.41 Inflammatory polyarthropathy (Shoulder region)
0.000 0.997 0.003
M06.98 Rheumatoid arthritis, unspecified (Other)
0.000 0.997 0.002
R82.9 Other and unspecified abnormal finding in urine
0.003 0.997 0.000
E27.1 Primary adrenocortical insufficiency
0.003 0.997 0.000
T51 Toxic effect of alcohol
0.003 0.997 0.000
M06.33 Rheumatoid nodule (Forearm)
0.000 0.997 0.002
T36 Poisoning by systemic antibiotics
0.003 0.997 0.000
D66 Hereditary factor VIII deficiency
0.000 0.997 0.003
K27 Peptic ulcer, site unspecified
0.003 0.997 0.000
E26 Hyperaldosteronism
0.003 0.997 0.000
M06.8 Other specified rheumatoid arthritis
0.000 0.997 0.002
R82.8 Abnormal findings on cytological and histological examination of urine
0.003 0.997 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.003 0.997 0.000
E23.7 Disorder of pituitary gland, unspecified
0.003 0.997 0.000
E34.0 Carcinoid syndrome
0.002 0.997 0.000
E23 Hypofunction and other disorders of pituitary gland
0.003 0.997 0.000
E20.8 Other hypoparathyroidism
0.002 0.997 0.000
E20.1 Pseudohypoparathyroidism
0.002 0.997 0.000
E20.0 Idiopathic hypoparathyroidism
0.002 0.997 0.000
K80.36 Calculus of bile duct with acute and chronic cholangitis without obstruction
0.002 0.997 0.000
E67 Other hyperalimentation
0.002 0.997 0.000
E68 Sequelae of hyperalimentation
0.002 0.997 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.002 0.997 0.000
T37.5 Antiviral drugs
0.002 0.997 0.000
T37.4 Anthelminthics
0.002 0.997 0.000
T37.3 Other antiprotozoal drugs
0.002 0.997 0.000
T37.1 Antimycobacterial drugs
0.002 0.997 0.000
T37.0 Sulphonamides
0.002 0.997 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.002 0.997 0.000
M06.32 Rheumatoid nodule (Upper arm)
0.000 0.997 0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.002 0.997 0.000
T50.4 Drugs affecting uric acid metabolism
0.002 0.997 0.000
E27 Other disorders of adrenal gland
0.003 0.997 0.000
R01.0 Benign and innocent cardiac murmurs
0.002 0.997 0.000
R16.2 Hepatomegaly with splenomegaly, not elsewhere classified
0.002 0.997 0.000
R82 Other abnormal findings in urine
0.003 0.997 0.000
M06.19 Adult-onset Still's disease (Site unspecified)
0.000 0.997 0.002
M06.18 Adult-onset Still's disease (Other)
0.000 0.997 0.002
M06.17 Adult-onset Still's disease (Ankle and foot)
0.000 0.997 0.002
M06.16 Adult-onset Still's disease (Lower leg)
0.000 0.997 0.002
M06.15 Adult-onset Still's disease (Pelvic region and thigh)
0.000 0.997 0.002
M06.14 Adult-onset Still's disease (Hand)
0.000 0.997 0.002
M06.13 Adult-onset Still's disease (Forearm)
0.000 0.997 0.002
M06.12 Adult-onset Still's disease (Upper arm)
0.000 0.997 0.002
M06.11 Adult-onset Still's disease (Shoulder region)
0.000 0.997 0.002
M06.10 Adult-onset Still's disease (Multiple sites)
0.000 0.997 0.002
M06.29 Rheumatoid bursitis (Site unspecified)
0.000 0.997 0.002
M06.28 Rheumatoid bursitis (Other)
0.000 0.997 0.002
M06.27 Rheumatoid bursitis (Ankle and foot)
0.000 0.997 0.002
M06.26 Rheumatoid bursitis (Lower leg)
0.000 0.997 0.002
M06.25 Rheumatoid bursitis (Pelvic region and thigh)
0.000 0.997 0.002
M06.24 Rheumatoid bursitis (Hand)
0.000 0.997 0.002
M06.23 Rheumatoid bursitis (Forearm)
0.000 0.997 0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2026 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.